INDIA’S LEADING VACCINE MAKER, INDIAN IMMUNOLOGICALS LTD, EXPANDS NEW ZEALAND OPERATIONS21 July 2022 Dr. K. Anand Kumar, Managing Director, Indian Immunologicals Ltd expresses his views with Indian Weekender, on IIL's expansion of its subsidiary, Pristine Biologicals in Dargaville North Island, New Zealand. Know more |
Indian Immunologicals Ltd to expand New Zealand Operations12 July 2022 The facility was inaugurated by Shri Meenesh C. Shah, Chairman of Indian Immunologicals Ltd and National Dairy Development Board, in the presence of Dr. Jason Smith, the Hon Mayor of Dargaville, Dr. K. Anand Kumar, Managing Director, IIL, Dr. Vijay Dasari, GM and Director, Pristine Biologicals (NZ) Limited and many dignitaries. Know more |
IIL's subsidiary Pristine Biologicals NZ inaugurates new sterile filtered serum manufacturing facility in Dargaville, New Zealand12 July 2022 Pristine Biologicals NZ Ltd, a subsidiary of Indian Immunologicals Ltd (IIL) - one of the largest producers of vaccines in India, which belongs to the National Dairy Development Board (NDDB) in India has inaugurated a new facility in Dargaville, New Zealand today for the production of sterile filtered serum. Know more |
Indian Immunologicals Ltd To Expand New Zealand Operations12 July 2022 The requirement for bovine serum from New Zealand for use in biologics manufacture has gone up many folds and to meet the demands of the world markets, it is important to augment the capacities and also bring in more value-added products, the company feels |
Pristine Biologicals inaugurates New Sterile Filtered Serum manufacturing facility in New Zealand’s Dargaville12 July 2022 The requirement for bovine serum from New Zealand for use in biologics manufacture has gone up many folds and to meet the demands of the world markets, it is important to augment the capacities and also bring in more value-added products, the company claimed. Know more |
Indian Immunologicals to expand New Zealand operations12 July 2022 Indian Immunologicals Limited (IIL), the vaccine maker under the National Dairy Development Board (NDDB), has announced expansion of operations in New Zealand through its subsidiary Pristine Biologicals NZ. Know more |
Pristine Biologicals inaugurates new facility in Dargaville, NZ12 July 2022 The facility was established in Dargaville, Kaipara District in 2015 for the production and supply of pharmaceutical grade bovine serum used to produce many vaccines and is considered a very successful venture. It is pertinent to note that the serum from New Zealand and Australia has premium value since those countries are free from OIE listed diseases. Know more |
IIL's subsidiary Pristine Biologicals NZ opens serum manufacturing facility in Dargaville, NZ12 July 2022 Pristine Biologicals NZ, a subsidiary of Indian Immunologicals Ltd (IIL) has inaugurated a new facility in Dargaville for the production of sterile-filtered serum. The facility was inaugurated by Meenesh C Shah, Chairman of Indian Immunologicals and National Dairy Development Board, in the presence of Dr Jason Smith, the Mayor of Dargaville, Dr K Anand Kumar, MD, IIL, Dr Vijay Dasari, GM and Director, Pristine Biologicals (NZ) and many dignitaries. Know more |
Indian Immunologicals launches Goat Pox Vaccine29 December 2021 Indian Immunologicals Ltd (IIL) has launched Goat Pox Vaccine (Raksha Goat Pox) which is expected to help Control of Goat Pox disease. Know more |
IIL donates oxygen generation plant to TIMS, Gachibowli13 December 2021 Indian Immunologicals Limited (IIL) donated a PSA Oxygen Generation Plant to the Telangana Institute of Medical Sciences (TIMS), Gachibowli for service to patients in need of oxygen support. Know more |
The pandemic’s silent saviours01 October 2021 We salute the scientists who’ve been working behind the scenes, combating the coronavirus Know more |
Govt lauds Indian Immunologicals for producing Covid-19 vaccine drug substance in record time24 September 2021 Hyderabad: Union Fisheries, Animal Husbandry, and Dairying minister Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for its ability to roll out Covid-19 vaccine drug substance in record time. Know more |
Union Minister Parshottam Rupala lauds IIL for producing COVID-19 drug substance in record time24 September 2021 New Delhi [India], September 24 (ANI): Union Fisheries, Animal Husbandry, and Dairying Minister, Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out the COVID-19 vaccine drug substance in record time. Know more |
Govt lauds IIL, BBIL's effort in COVID-19 vaccine production24 September 2021 Union Fisheries, Animal Husbandry, and Dairying Minister, Parshottam Rupala hands over COVID-19 drug substance made at IIL to Dr Krishna Ella, CMD, BBIL Know more |
Indian Immunologicals to ramp up production of input for Covaxin24 September 2021 This was disclosed by the Hyderabad-based IIL during the visit of Union Minister Parshottam Rupala Know more |
Union Minister Parshottam Rupala lauds IIL for producing COVID-19 drug substance in record time24 September 2021 New Delhi [India], September 24 (ANI): Union Fisheries, Animal Husbandry, and Dairying Minister, Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out the COVID-19 vaccine drug substance in record time. Know more |
Indian Immunologicals Limited to make 10 million doses of Covaxin drug substance from Dec24 September 2021 Indian Immunologicals Limitedis also developing on a live attenuated COVID-19 vaccine which has many advantages and will be rolled out next year. Know more |
IHWDigitalHealth Awards 202119 August 2021 Human Biologicals Institute (A division of Indian Immunologicals Limited) has received the gold award in the category of “Communication Solutions” in the IHWDigitalHealth Awards 2021 for its public awareness initiative "Fearless against rabies" Know more |
IIL starts Covaxin drug substance supply to Bharat Bio for 3-4 million doses per month13 August 2021 HYDERABAD: In a move that will immediately augment the production capacity of indigenously developed Covid-19 Covaxin, Indian Immunologicals Ltd (IIL) on Friday handed over the first batch of the Covaxin drug substance to Bharat Biotech. Know more |
Veterinary and human vaccines maker, Indian Immunologicals Limited (IIL), has launched the Classical Swine Fever (CSF) vaccine under the brand name ‘Raksha Class’03 June 2020 Veterinary and human vaccines maker, Indian Immunologicals Limited (IIL), has launched the Classical Swine Fever (CSF) vaccine under the brand name ‘Raksha Class’. Know more |